IVC Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$445K Sell
1,767
-58
-3% -$12.5K 0.17% 105
2026
Q1
$397K Sell
1,825
-19
-1% -$4.21K 0.17% 104
2025
Q4
$421K Buy
1,844
+305
+20% +$69.5K 0.18% 101
2025
Q3
$356K Buy
1,539
+100
+7% +$20.4K 0.16% 117
2025
Q2
$267K Sell
1,439
-39
-3% -$7.25K 0.13% 141
2025
Q1
$310K Sell
1,478
-23
-2% -$4.47K 0.17% 122
2024
Q4
$267K Sell
1,501
-36
-2% -$6.62K 0.15% 131
2024
Q3
$304K Sell
1,537
-64
-4% -$11.9K 0.17% 122
2024
Q2
$275K Sell
1,601
-153
-9% -$25.3K 0.15% 128
2024
Q1
$319K Buy
1,754
+112
+7% +$19.3K 0.18% 116
2023
Q4
$254K Sell
1,642
-62
-4% -$9.04K 0.16% 127
2023
Q3
$254K Buy
+1,704
New +$250K 0.17% 119
2023
Q2
Sell
-1,498
Closed -$239K 161
2023
Q1
$239K Sell
1,498
-146
-9% -$22.3K 0.17% 121
2022
Q4
$266K Sell
1,644
-2
-0.1% -$307 0.2% 116
2022
Q3
$221K Buy
1,646
+114
+7% +$16.4K 0.18% 128
2022
Q2
$235K Buy
1,532
+1
+0.1% +$153 0.18% 121
2022
Q1
$248K Buy
+1,531
New +$222K 0.16% 128

Other funds holding ABBV

IVC Wealth Advisors's ABBV Position: Q2 2026 in Review

IVC Wealth Advisors reduced its AbbVie (ABBV) stake by 3.2% in Q2 2026, selling an estimated $12.5K and leaving 1,767 shares worth $445K. The position accounts for 0.17% of the portfolio, ranked #105.

IVC Wealth Advisors first reported a position in ABBV in Q1 2022 and has held it in 17 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • IVC Wealth Advisors held 1,767 shares of AbbVie worth $445K as of Q2 2026.
  • IVC Wealth Advisors sold 58 AbbVie shares in Q2 2026, an estimated $12.5K.
  • AbbVie made up 0.17% of IVC Wealth Advisors's portfolio in Q2 2026, its #105 holding.
  • IVC Wealth Advisors first reported a position in AbbVie in Q1 2022 and has held it in 17 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on IVC Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.